Related references
Note: Only part of the references are listed.Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease
C. Steenholdt et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Acute infusion reactions induced by monoclonal antibody therapy
Enrico Maggi et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2011)
Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease
Casper Steenholdt et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions
A. Vultaggio et al.
ALLERGY (2010)
Adverse effects of biologics used for treating IBD
Andreas Stallmach et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2010)
A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease
W. Miehsler et al.
JOURNAL OF CROHNS & COLITIS (2010)
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects
Matthieu Allez et al.
JOURNAL OF CROHNS & COLITIS (2010)
Serum sickness, encephalitis and other complications of anti-cytokine therapy
Severine Vermeire et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2009)
Incidence and Clinical Significance of Immunogenicity to Infliximab in Crohn's Disease: A Critical Systematic Review
Andrea Cassinotti et al.
INFLAMMATORY BOWEL DISEASES (2009)
American Gastroenterological Association Consensus Development Conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006
M. Clark et al.
GASTROENTEROLOGY (2007)
Urticaria and angiedema-like skin reactions in a patient treated with adalimumab
S. N. Nikas et al.
CLINICAL RHEUMATOLOGY (2007)
Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor α inhibitor infliximab
Klaus Bendtzen et al.
ARTHRITIS AND RHEUMATISM (2006)
Clinical and biological consequences of immunization to infliximab in pediatric Crohn's disease
S Candon et al.
CLINICAL IMMUNOLOGY (2006)
Managing immunogenic responses to infliximab - Treatment implications for patients with Crohn's disease
PD Han et al.
DRUGS (2004)
Incidence and Importance of Antibody Responses to Infliximab After Maintenance or Episodic Treatment in Crohn's Disease
Stephen B. Hanauer et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Vaccination for birch pollen allergy - Induction of affinity-matured or blocking IgG antibodies does not account for the reduced binding of IgE to Bet v 1
M Svenson et al.
MOLECULAR IMMUNOLOGY (2003)
Share Paper
